Careers  |  Sign In  |  Register  |   Twitter

Latest in Pharmacists

Reuters Health • The Doctor's Channel Daily Newscast

Lipid-lowering therapy improves atrial fibrillation outcomes

NEW YORK (Reuters Health) – Lipid-lowering therapy reduces cardiovascular events and all-cause mortality in patients with atrial fibrillation, according to a post hoc analysis of the AFFIRM study. This is “one of the first studies to show a relationship between use of lipid-lowering therapy and...

Reuters Health • The Doctor's Channel Daily Newscast

Annual high-dose vitamin D supplement may be counterproductive

NEW YORK (Reuters Health) – A single yearly oral dose of 500,000 international units of cholecalciferol (vitamin D) does not protect generally healthy older women from falls and fractures. On the contrary, it appears to increase the risk of falls and fractures, researchers from Australia found in a...

Reuters Health • The Doctor's Channel Daily Newscast

Pramipexole reduces depressive symptoms in Parkinson’s patients

NEW YORK (Reuters Health) – The dopamine agonist pramipexole relieves depressive symptoms in patients with Parkinson’s disease, according to a study published online May 10th in The Lancet Neurology. More than a third of patients with Parkinson’s disease have clinically significant depression, and the...